Comparison of arbutamine stress 99mTc-labeled sestamibi single-photon emission computed tomographic imaging and echocardiography for detection of the extent and severity of coronary artery disease and inducible ischemia
- PMID: 9199258
- DOI: 10.1016/s1071-3581(97)90081-7
Comparison of arbutamine stress 99mTc-labeled sestamibi single-photon emission computed tomographic imaging and echocardiography for detection of the extent and severity of coronary artery disease and inducible ischemia
Abstract
Background: Arbutamine is a new synthetic catecholamine developed specifically for pharmacologic stress testing.
Methods and results: We investigated 39 patients undergoing coronary arteriography to compare arbutamine stress (99m)Tc-labeled sestamibi single-photon emission computed tomographic imaging and echocardiography for detection of the extent and severity of coronary artery disease and inducible ischemia. Rest and stress studies were analyzed blindly according to a 12-segment left ventricular model for both techniques. Each segment was graded according to severity of wall thickening abnormality and perfusion defect (1 = normal to 4 = severe). Total perfusion defect and wall thickening scores were calculated at peak stress and the difference in scores between stress and rest (delta perfusion defect; delta wall thickening) were used as indexes of inducible ischemia. Twenty-one patients had multivessel disease, nine had single-vessel disease, and nine had normal coronary arteries. Diagnostic accuracies for the detection of coronary artery disease for single-photon emission computed tomographic imaging and echocardiography were 95% and 92%, respectively. Extent and severity of coronary artery disease indicated by a peak stress perfusion defect score of 26 +/- 6.4 and wall thickening score of 25.1 +/- 8.4 were similar, and there was no significant difference in the delta perfusion defect and delta wall thickening scores of 8.7 +/- 5.5 and 10.4 +/- 7.1, respectively. Segmental concordance rates for the detection of coronary artery disease and inducible ischemia were 74% (K = 0.47; confidence interval 0.39 to 0.55) and 74% (kappa = 0.42; confidence interval 0.34 to 0.51), respectively. Regional concordance for coronary artery disease was 84% (kappa = 0.68; confidence interval 0.51 to 0.84). Where discordance was present, there was a greater prevalence of perfusion abnormality compared with wall thickening abnormality.
Conclusion: Arbutamine stress single-photon emission computed tomographic imaging and echocardiography provide largely equivalent and accurate pathophysiologic information for the evaluation of coronary artery disease and inducible ischemia.
Similar articles
-
Inotropic stress with arbutamine is superior to vasodilator stress with dipyridamole for the detection of reversible ischemia with Tc-99m sestamibi single-photon emission computed tomography.J Nucl Cardiol. 1997 Sep-Oct;4(5):364-71. doi: 10.1016/s1071-3581(97)90027-1. J Nucl Cardiol. 1997. PMID: 9362012
-
Combined analysis of resting regional wall thickening and stress perfusion with electrocardiographic-gated technetium 99m-labeled sestamibi single-photon emission computed tomography: prediction of stress defect reversibility.J Nucl Cardiol. 1997 Jan-Feb;4(1 Pt 1):3-10. doi: 10.1016/s1071-3581(97)90043-x. J Nucl Cardiol. 1997. PMID: 9138837
-
Direct comparison of arbutamine and dobutamine stress testing with myocardial perfusion imaging and echocardiography in patients with coronary artery disease.Am J Cardiol. 1997 Sep 15;80(6):716-20. doi: 10.1016/s0002-9149(97)00501-8. Am J Cardiol. 1997. PMID: 9315575 Clinical Trial.
-
Pharmacological stress testing.Semin Nucl Med. 1999 Oct;29(4):298-318. doi: 10.1016/s0001-2998(99)80018-x. Semin Nucl Med. 1999. PMID: 10534233 Review.
-
Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.Am J Cardiol. 1990 Oct 16;66(13):55E-62E. doi: 10.1016/0002-9149(90)90613-6. Am J Cardiol. 1990. PMID: 2145748 Review.
Cited by
-
Prognostic validation of an algorithm to convert myocardial perfusion SPECT imaging data from a 12-segment model to a 17-segment model.J Nucl Cardiol. 2009 Jul-Aug;16(4):605-13. doi: 10.1007/s12350-009-9103-z. Epub 2009 Jun 3. J Nucl Cardiol. 2009. PMID: 19495902 Free PMC article.
-
Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease.Heart. 2003 Nov;89(11):1291-7. doi: 10.1136/heart.89.11.1291. Heart. 2003. PMID: 14594881 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
